Long-Acting Therapeutic Options for HIV Treatment and Prevention: A Review of Clinical Data - Sharon Walmsley, C.M. MD, FRCPC

GCC HIV Clinical Forum 2022

Treatment Optimalization in Suppressed PLWH - Is 2DR an Option? - Ahmad Alharbi, MD

GCC HIV Clinical Forum 2022

New Available Options - Switching the Treatment of HIV - Aqeel Saleem, MD

GCC HIV Clinical Forum 2022

Clinical Management of People Living with HIV and Comorbidities (+ CVD) - Jehad Abdalla, MD

GCC HIV Clinical Forum 2022

Early Diagnosis and Same-Day ART - Laura Waters, MD, FRCP

GCC HIV Clinical Forum 2022

Resistance Considerations When Choosing Optimal Treatment - Laura Waters, MD, FRCP

GCC HIV Clinical Forum 2022

Two-Drug Regimen - Selecting the Right Patient - Sharon Walmsley, C.M. MD, FRCPC

GCC HIV Clinical Forum 2022

People Living with HIV with Limited Treatment Options - Jürgen Rockstroh, MD

GCC HIV Clinical Forum 2022

Two-Drug Regimen - Sharing Experiences / Real World Evidence - Jürgen Rockstroh, MD

GCC HIV Clinical Forum 2022

Pharmacological Considerations When Choosing Optimal Treatment Regimen - Marta Boffito, MD, PhD, FRCP

GCC HIV Clinical Forum 2022

Clinical Considerations of Aging People Living with HIV - Marta Boffito, MD, PhD, FRCP

GCC HIV Clinical Forum 2022